<VariationArchive RecordType="classified" VariationID="375474" VariationName="NM_000286.3(PEX12):c.765_766dup (p.Phe256fs)" VariationType="Duplication" Accession="VCV000375474" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-11-21" MostRecentSubmission="2019-11-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="362280" VariationID="375474">
      <GeneList>
        <Gene Symbol="PEX12" FullName="peroxisomal biogenesis factor 12" GeneID="5193" HGNC_ID="HGNC:8854" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35574795" stop="35578571" display_start="35574795" display_stop="35578571" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33901813" stop="33905655" display_start="33901813" display_stop="33905655" Strand="-" />
          </Location>
          <OMIM>601758</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000286.3(PEX12):c.765_766dup (p.Phe256fs)</Name>
      <CanonicalSPDI>NC_000017.11:35576095:ATA:ATATA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35576095" stop="35576096" display_start="35576095" display_stop="35576096" variantLength="2" positionVCF="35576095" referenceAlleleVCF="A" alternateAlleleVCF="AAT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33903114" stop="33903115" display_start="33903114" display_stop="33903115" variantLength="2" positionVCF="33903114" referenceAlleleVCF="A" alternateAlleleVCF="AAT" />
      </Location>
      <ProteinChange>F256fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.33903116_33903117dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.33903116_33903117dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.35576097_35576098dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.35576097_35576098dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008447.1" sequenceAccession="NG_008447" sequenceVersion="1" change="g.7541_7542dup">
            <Expression>NG_008447.1:g.7541_7542dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000286.3" sequenceAccession="NM_000286" sequenceVersion="3" change="c.765_766dup" MANESelect="true">
            <Expression>NM_000286.3:c.765_766dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000277.1" sequenceAccession="NP_000277" sequenceVersion="1" change="p.Phe256fs">
            <Expression>NP_000277.1:p.Phe256fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16044285" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601758.0012" DB="OMIM" />
        <XRef Type="rs" ID="1057519507" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 26094004 Fig. 1B to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000286.3(PEX12):c.765_766dup (p.Phe256fs) AND Peroxisome biogenesis disorder 3A (Zellweger)" Accession="RCV000416562" Version="5">
        <ClassifiedConditionList TraitSetID="8948">
          <ClassifiedCondition DB="MedGen" ID="C3553929">Peroxisome biogenesis disorder 3A (Zellweger)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2019-11-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-11-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-11-21" MostRecentSubmission="2019-11-21">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26094004</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17429" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Peroxisome biogenesis disorder 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 3A (Zellweger)</ElementValue>
                <XRef ID="MONDO:0013927" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
                <XRef Type="Allelic variant" ID="601758.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="601758.0005" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PBD3A</ElementValue>
                <XRef ID="GTR000522760" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome resulting from disordered peroxisome biogenesis. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006).
For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100.
Individuals with PBDs of complementation group 3 (CG3) have mutations in the PEX12 gene. For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614859" DB="OMIM" />
              </AttributeSet>
              <XRef ID="912" DB="Orphanet" />
              <XRef ID="C3553929" DB="MedGen" />
              <XRef ID="MONDO:0013927" DB="MONDO" />
              <XRef Type="MIM" ID="614859" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="966992" SubmissionDate="2019-11-18" DateLastUpdated="2019-11-21" DateCreated="2017-02-06">
        <ClinVarSubmissionID localKey="601758.0012_PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)" title="PEX12, 2-BP DUP, 767AT_PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)" />
        <ClinVarAccession Accession="SCV000494457" DateUpdated="2019-11-21" DateCreated="2017-02-06" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-11-18">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient from Slovakia with Zellweger syndrome (PBD3A; 614859) who died at the age of 23 days, Konkolova et al. (2015) detected a novel 2-bp duplication (c.767_768dupAT) in exon 3 of the PEX12 gene, in compound heterozygosity with a 2-bp deletion (c.887_888delTC; 601758.0011). The duplication resulted in a frameshift after phe256 followed by premature termination after an additional 22 amino acids, truncating the C-terminal zinc-binding domain.</Attribute>
              <Citation>
                <ID Source="PubMed">26094004</ID>
              </Citation>
              <XRef DB="OMIM" ID="614859" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX12" />
          </GeneList>
          <Name>PEX12, 2-BP DUP, 767AT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DUP, 767AT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601758.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="966992" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOMAL BIOGENESIS DISORDER 3A (ZELLWEGER)" MappingRef="Preferred">
        <MedGen CUI="C3553929" Name="Peroxisome biogenesis disorder 3A (Zellweger)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

